Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$17.13 - $23.74 $283,227 - $392,517
16,534 Added 1.64%
1,027,751 $19.3 Million
Q1 2023

May 12, 2023

BUY
$19.34 - $24.11 $12.3 Million - $15.4 Million
637,734 Added 170.75%
1,011,217 $22.8 Million
Q4 2022

Feb 10, 2023

BUY
$12.64 - $25.52 $4.72 Million - $9.53 Million
373,483 New
373,483 $9.48 Million
Q3 2021

Nov 09, 2021

SELL
$23.42 - $37.93 $9.26 Million - $15 Million
-395,584 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$26.65 - $39.47 $912,682 - $1.35 Million
-34,247 Reduced 7.97%
395,584 $13.6 Million
Q1 2021

May 11, 2021

BUY
$31.9 - $36.0 $13.7 Million - $15.5 Million
429,831 New
429,831 $15.5 Million

Others Institutions Holding OLK

About Olink Holding AB (publ)


  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Market Cap $3.1B
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.